MAPT and Alzheimer disease: Moreover, female ApoE4 carriers display more severe amyloid-beta pathology, quicker cognitive decline, and a more significant accumulation of tau tangles than their male counterparts, emphasizing the interaction between sex and genetic risk in AD progression.